logo
Share SHARE
FONT-SIZE Plus   Neg

Nanosphere Obtains CE Mark For Gram-Negative Blood Culture Test

Healthcare company Nanosphere, Inc. (NSPH) Wednesday said it has obtained the CE IVD Mark, under the European Directive on In Vitro Diagnostic Medical Devices, for its Gram-Negative Blood Culture test or BC-GN on the automated sample-to-result Verigene System.

The CE IVD Mark is a requirement for in vitro diagnostic medical devices marketed in Europe.

The company said the test expands its infectious disease test capabilities to include rapid detection of bacteria that can cause deadly bloodstream infections. It further added that, with a single automated test, the Verigene BC-GN test provides rapid genus and species level detection for a broad panel of clinically significant gram-negative bacteria and also detects critical genetic markers of antimicrobial resistance, including KPC, NDM, CTX-M, OXA, VIM, and IMP.

Commenting on the development, Michael McGarrity, Nanosphere's Chief Executive Officer said, "The Gram-Negative Blood Culture test provides clinicians a revolutionary diagnostic tool for the simultaneous detection of disease-causing gram-negative bacteria and accompanying antibiotic resistance markers in a clinically actionable timeframe."

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Boeing Co.(BA) reported a loss for the second-quarter 2016 compared to profit in the prior year, reflecting 787 cost reclassification and charges on the 747 program and the KC-46 Tanker program, partially offset by solid execution and higher volume. It cut its profit outlook for fiscal year 2016, while it reaffirmed annual revenue guidance. Automaker Fiat Chrysler Automobiles NV on Wednesday reported a 25 percent increase in profit for the second quarter from last year. However, quarterly net revenues and worldwide shipments declined from last year. Coca-Cola Co. (KO) posted a profit for the second-quarter that increased 11 percent from last year, while net operating revenues declined 5 percent. It is targeting full-year 2016 net share repurchases of $2.0 billion to $2.5 billion.
comments powered by Disqus
Follow RTT